Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-61.01	18.82	48.28
Graham Fair Price	81.97	5799.93	3187.22
PEG	-91.34	0.03	-0.37
Price/Book	16.67	0.81	0.70
Price/Cash Flow	inf	0.00	16.35
Prices/Earnings	-59.88	6.67	16.63
Price/Sales	9.46	1.51	1.38
Price/FCF	inf	0.00	16.35
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	20.69	0.16	0.14
Operating Margin	70.87	0.08	0.05
ROA	202.97	0.01	< 0.005
ROE	0.01	0.03	190.77
ROIC	< 0.005	0.02	163.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.10	-0.02	562.62
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.23	0.94	310.33
EPS QOQ	-0.45	2.10	363.33
FCF QOQ	< 0.005	-1.00	-16337.50
Revenue QOQ	-0.01	0.14	1192.23
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	20.16	13.81	-31.47
Days Sales Outstanding (DSO)	119.25	107.09	-10.20
Inventory Turnover	4.47	6.52	45.93
Debt/Capitalization	0.41	0.27	-32.56
Quick Ratio	1.44	1.47	2.07
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	6570.08	7011.43	6.72
Cash	1496.50	2127.63	42.17
Capex	0.00	0.00	0.00
Free Cash Flow	279.58	0.00	inf
Revenue	3309.69	3764.73	13.75
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.63	1.63	-0.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.55	6.39	-67.30
Naive Interpretation	Member

06 - Financial Health · Weak

Rating